With diagnostic capabilities always evolving, Joanne Bradley explains why she believes the time is right for mass spectrometry to make the move from specialist settings into routine clinical use.
As laboratories across the UK continue to navigate rising testing demands, workforce pressures, and the shift towards personalised medicine, the question of how we evolve our diagnostic capabilities is more relevant than ever.
The government’s recently published 10-Year Health Plan sets out a clear ambition to move towards a more preventative healthcare model, using earlier detection and intervention to improve outcomes and reduce pressures across the system.1 Diagnostics sits at the heart of this vision, providing the data needed to inform timely, targeted care.
Mass spectrometry, with its well-established reputation for precision, could play a greater role in supporting this shift – if it can be brought from specialist settings into routine clinical use.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.